Cylene Pharmaceuticals logo — company profile

Cylene Pharmaceuticals

Founded 2001 Debt Financing Total: $102.30M Biotechnology, Health Care +1

General Information

Company Name Cylene Pharmaceuticals
Founded Year 2001
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Cylene Pharmaceuticals. To contact Cylene Pharmaceuticals, visit cylenepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cylene Pharmaceuticals compare?

A PDF of Cylene Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cylene Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cylene Pharmaceuticals

is a biotech pharmaceutical company established in 2001 in San Diego, California. The company is focused on discovering, developing, and bringing to market small molecule drugs that specifically target the nucleolus to eliminate cancer cells. Cylene Pharmaceuticals specializes in producing nucleolus targeting agents designed for treating carcinoid/neuroendocrine tumors and pediatric brain tumors, along with serine/threonine protein kinase inhibitors. The company also offers pre-clinical stage oral drug candidates. In January 2013, Cylene Pharmaceuticals received a $867.00K debt financing investment. The company was originally established in 1997 under the name Cyternex, Inc. before rebranding to its current name in October 2003. With a focus on addressing critical medical needs through innovative pharmaceutical solutions, Cylene Pharmaceuticals presents potential opportunities for investment in the biotechnology, health care, and pharmaceutical industries.

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $867.00K -
22 Jan 2013
Debt Financing $15.64M -
11 Aug 2011
Series D $12.00M 6
HBM Healthcare Investments, Novartis Venture Fund +4
24 Sep 2010
Series C $44.00M 7
HBM Healthcare Investments, BioVentures Investors +5
23 Jan 2007
Series B $26.30M 6
BioVentures Investors, Mitsui Global Investment +4
26 May 2005
Series A $3.50M 4
Novartis Venture Fund, Sanderling Ventures +2
17 Oct 2001

Cylene Pharmaceuticals Alternatives & Competitors

View All Alternatives
Cylene Pharmaceuticals vs

Pioneering marine microbiology to develop advanced treatments for cancer, infections, and inflammati...

Series E
Biotechnology, Health Care
Cylene Pharmaceuticals vs

Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune dis...

Series B
Biotechnology, Health Care
Cylene Pharmaceuticals vs

Innovating patient care with advanced small molecule therapies for severe medical conditions, includ...

Post-IPO Equity
Biotechnology, Health Care

FAQ About Cylene Pharmaceuticals

Cylene Pharmaceuticals, Inc. is a biotech pharmaceutical company focused on discovering, developing, and bringing to market small molecule drugs that specifically target the nucleolus to eliminate cancer cells. The company specializes in producing nucleolus targeting agents designed for treating car...
Cylene Pharmaceuticals was founded in 2001.
Cylene Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical.
Cylene Pharmaceuticals has completed 6 funding rounds, raising a total of $102.30M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Cylene Pharmaceuticals include Nereus Pharmaceuticals, VentiRx Pharmaceuticals, Synta Pharmaceuticals, Proacta, Tarveda Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cylene Pharmaceuticals and Nereus Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cylene Pharmaceuticals, https://bouncewatch.com/company/cylene-pharmaceuticals, updated 26 July 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes